vs
Side-by-side financial comparison of ACADIA REALTY TRUST (AKR) and STEM, INC. (STEM). Click either name above to swap in a different company.
ACADIA REALTY TRUST is the larger business by last-quarter revenue ($103.0M vs $47.1M, roughly 2.2× STEM, INC.). ACADIA REALTY TRUST runs the higher net margin — 135.1% vs -33.9%, a 169.0% gap on every dollar of revenue. On growth, ACADIA REALTY TRUST posted the faster year-over-year revenue change (-1.3% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs 7.0%).
Acadia Realty Trust is a publicly traded real estate investment trust (REIT) that specializes in owning, operating, and redeveloping high-quality retail and mixed-use properties, primarily in dense, high-barrier-to-entry U.S. markets. Its portfolio includes neighborhood shopping centers, urban street retail assets, and community-focused mixed-use developments.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
AKR vs STEM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $103.0M | $47.1M |
| Net Profit | $139.1M | $-16.0M |
| Gross Margin | — | 48.9% |
| Operating Margin | 153.9% | -17.7% |
| Net Margin | 135.1% | -33.9% |
| Revenue YoY | -1.3% | -15.6% |
| Net Profit YoY | -58.2% | 68.8% |
| EPS (diluted) | — | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $103.0M | — | ||
| Q4 25 | — | $47.1M | ||
| Q3 25 | — | $38.2M | ||
| Q2 25 | — | $38.4M | ||
| Q1 25 | — | $32.5M | ||
| Q4 24 | $93.3M | $55.8M | ||
| Q3 24 | $87.7M | $29.3M | ||
| Q2 24 | $87.3M | $34.0M |
| Q1 26 | $139.1M | — | ||
| Q4 25 | — | $-16.0M | ||
| Q3 25 | — | $-23.8M | ||
| Q2 25 | — | $202.5M | ||
| Q1 25 | — | $-25.0M | ||
| Q4 24 | $1.2M | $-51.1M | ||
| Q3 24 | $12.3M | $-148.3M | ||
| Q2 24 | $1.6M | $-582.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% |
| Q1 26 | 153.9% | — | ||
| Q4 25 | — | -17.7% | ||
| Q3 25 | — | -33.6% | ||
| Q2 25 | — | -34.8% | ||
| Q1 25 | — | -65.0% | ||
| Q4 24 | 17.5% | -84.4% | ||
| Q3 24 | 19.9% | -493.2% | ||
| Q2 24 | 20.4% | -1705.5% |
| Q1 26 | 135.1% | — | ||
| Q4 25 | — | -33.9% | ||
| Q3 25 | — | -62.2% | ||
| Q2 25 | — | 527.8% | ||
| Q1 25 | — | -76.9% | ||
| Q4 24 | 1.2% | -91.6% | ||
| Q3 24 | 14.0% | -506.3% | ||
| Q2 24 | 1.8% | -1712.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | $-4.40 | ||
| Q3 25 | — | $-2.84 | ||
| Q2 25 | — | $-1.79 | ||
| Q1 25 | — | $-0.15 | ||
| Q4 24 | $0.08 | $-15.29 | ||
| Q3 24 | $0.07 | $-18.24 | ||
| Q2 24 | $0.01 | $-71.81 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.4M | $48.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.6B | $-249.4M |
| Total Assets | $4.5B | $308.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $31.4M | — | ||
| Q4 25 | — | $48.9M | ||
| Q3 25 | — | $43.1M | ||
| Q2 25 | — | $40.8M | ||
| Q1 25 | — | $58.6M | ||
| Q4 24 | $16.8M | $56.3M | ||
| Q3 24 | $46.2M | $75.4M | ||
| Q2 24 | $31.9M | $89.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.7B | — |
| Q1 26 | $2.6B | — | ||
| Q4 25 | — | $-249.4M | ||
| Q3 25 | — | $-235.7M | ||
| Q2 25 | — | $-214.1M | ||
| Q1 25 | — | $-417.5M | ||
| Q4 24 | $2.1B | $-398.4M | ||
| Q3 24 | $1.9B | $-344.1M | ||
| Q2 24 | $1.8B | $-203.2M |
| Q1 26 | $4.5B | — | ||
| Q4 25 | — | $308.9M | ||
| Q3 25 | — | $362.6M | ||
| Q2 25 | — | $379.2M | ||
| Q1 25 | — | $405.1M | ||
| Q4 24 | $4.4B | $437.4M | ||
| Q3 24 | $4.3B | $537.8M | ||
| Q2 24 | $4.3B | $691.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 0.82× | — | ||
| Q2 24 | 0.95× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | — | $8.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 1.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $8.2M | ||
| Q3 25 | — | $11.4M | ||
| Q2 25 | — | $-21.3M | ||
| Q1 25 | — | $8.5M | ||
| Q4 24 | $140.4M | $-14.7M | ||
| Q3 24 | $44.6M | $-9.4M | ||
| Q2 24 | $32.0M | $-11.9M |
| Q1 26 | 1.7% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | 121.08× | — | ||
| Q3 24 | 3.64× | — | ||
| Q2 24 | 20.25× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AKR
| Rental | $98.6M | 96% |
| Other | $4.4M | 4% |
STEM
Segment breakdown not available.